Sweden · Delayed Price · Currency is SEK Isofol Medical AB Statistics
Total Valuation
STO:ISOFOL has a market cap or net worth of SEK 245.97 million. The enterprise value is 118.98 million.
| Market Cap | 245.97M |
| Enterprise Value | 118.98M |
Important Dates
The last earnings date was Wednesday, February 18, 2026.
| Earnings Date | Feb 18, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
STO:ISOFOL has 281.11 million shares outstanding. The number of shares has increased by 34.15% in one year.
| Current Share Class | 281.11M |
| Shares Outstanding | 281.11M |
| Shares Change (YoY) | +34.15% |
| Shares Change (QoQ) | +6.92% |
| Owned by Insiders (%) | 18.33% |
| Owned by Institutions (%) | 13.25% |
| Float | 195.01M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 2.28 |
| P/TBV Ratio | 2.28 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.20 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.19
| Current Ratio | 6.19 |
| Quick Ratio | 6.14 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -55,983.00 |
Financial Efficiency
Return on equity (ROE) is -58.30% and return on invested capital (ROIC) is -37.66%.
| Return on Equity (ROE) | -58.30% |
| Return on Assets (ROA) | -30.72% |
| Return on Invested Capital (ROIC) | -37.66% |
| Return on Capital Employed (ROCE) | -51.61% |
| Weighted Average Cost of Capital (WACC) | 8.83% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -9.03M |
| Employee Count | 6 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -48.41% in the last 52 weeks. The beta is 0.83, so STO:ISOFOL's price volatility has been lower than the market average.
| Beta (5Y) | 0.83 |
| 52-Week Price Change | -48.41% |
| 50-Day Moving Average | 0.68 |
| 200-Day Moving Average | 0.83 |
| Relative Strength Index (RSI) | 75.67 |
| Average Volume (20 Days) | 2,881,187 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | -40.16M |
| Operating Income | -55.98M |
| Pretax Income | -54.17M |
| Net Income | -54.17M |
| EBITDA | -55.98M |
| EBIT | -55.98M |
| Earnings Per Share (EPS) | -0.25 |
Balance Sheet
The company has 126.99 million in cash and n/a in debt, with a net cash position of 126.99 million or 0.45 per share.
| Cash & Cash Equivalents | 126.99M |
| Total Debt | n/a |
| Net Cash | 126.99M |
| Net Cash Per Share | 0.45 |
| Equity (Book Value) | 107.87M |
| Book Value Per Share | 0.38 |
| Working Capital | 108.48M |
Cash Flow
| Operating Cash Flow | -51.94M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
STO:ISOFOL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -34.15% |
| Shareholder Yield | -34.15% |
| Earnings Yield | -22.02% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |